Human Lymphokines. The Biological Immune Response Modifiers

Content: 
Front Matter, Page iii
Copyright, Page iv
CONTRIBUTORS, Pages xi-xviii
PREFACE, Page xix
ACKNOWLEDGMENTS, Page xxi
POLYCLONAL B CELL ACTIVATOR IN RHEUMATIC DISEASES, Pages 1-7, John L. Skosey, Gerald M. Eisenberg, Tieh T. Lee, Marius Teodorescu
INTERFERON ACTIVATES MACROPHAGES TO PRODUCE PLASMINOGEN ACTIVATOR, Pages 9-21, C. Michael Jones, Luigi Varesio, Ronald B. Herberman, Sidney Pestka
A STANDARDIZED AUTOMATED COMPUTER ASSISTED MICRO-ASSAY FOR LYMPHOTOXIN, Pages 23-32, Amanullah Khan, David Weldon, John Duvall, Sathit Pitchyangkul, N.O. Hill, David Muntz, Robert Lanius, Mike Ground
PROBLEMS ASSOCIATED WITH RESEARCH ON HUMAN MIF, Pages 33-40, Udo Schwulera, Hans H. Sonneborn, Ursula Otz
THE MOTILITY OF THE CELLS OF A LYMPHOBLASTOID CELL, QIMR-WIL, IS INHIBITED BY HUMAN AND MURINE LEUKOCYTE INHIBITORY FACTOR, Pages 41-55, Eric J. Culbert, Alistair J. Cochran, Duan-Ren Wen, Geoffrey B. Clements
A STANDARDIZED AND RAPID MIF ASSAY USING U-937 CELL LINE AND OPTICAL DENSITY MEASUREMENT, Pages 57-65, Kirpal Singh, Amanullah Khan
MACROPHAGE ACTIVATION BY LYMPHOKINE FACTORS (MAF) AS MEASURED BY PHAGOCYTOSIS, METABOLIC PRODUCTS, AND TUMOR CELL CYTOTOXICITY: CORRELATION OF MULTIPARAMETER FUNCTIONAL ASSAYS, Pages 67-84, Pamela A. Dunn, William R. Eaton, Eric Lopatin, Harry Tyrer, John E. McEntire, Ben W. Papermaster, Archibald Miller, Gerald Vosika
STANDARDIZATION OF THE INDIRECT LIF TEST BY REFERENCE TO LYMPHOID CELL-LINE LYMPHOKINE (LCL-LK) AS A STANDARD MATERIAL, Pages 85-95, Anne S. Hamblin, Barbara Zawisza, U. Shipton, D.C. Dumonde, Frank den Hollander, H. Verheul, A. Schuurs
VALUE OF REFERENCE PREPARATIONS IN LYMPHOKINE TESTS, Pages 97-108, H. Verheul, F. den Hollander, D. Dijkhuizen, J. Kessels, A. van Doornmalen, A. Schuurs
SEMIMICROMODIFICATION OF THE INDIRECT MIGRATION INHIBITION / MIF PRODUCTION / TEST, Pages 109-123, Jan Švejcar, Jan Pekárek, Jozef Rovenský
INDUCTION AND AUGMENTATION OF MITOGEN-INDUCED LYMPHOKINE PRODUCTION IN HUMAN PBL BY Nα-DESACETYLTHYMOSIN α1, Pages 125-133, L.P. Svedersky, A. Hui, G. Don, D. Wheeler, P. McKay, L. May, N. Stebbing
PRODUCTION OF HUMAN INTERLEUKIN-2(TCGF) USING SERUM FREE CULTURE CONDITIONS, Pages 135-145, Laurence B. Sohook, Flemming Kristensen, Ursula Otz, Sandor Lazary, Alain L. de Weck
MORPHOLOGICAL CHARACTERISTICS OF INTERFERON-PRODUCING CELLS IN HUMAN PERIPHERAL BLOOD, Pages 147-153, Jochen Abb, Hannelore Abb, Friedrich Deinhardt
RAPID PRODUCTION OF HIGH LEVELS OF GAMMA INTERFERON BY HUMAN THORACIC DUCT LEUKOCYTES STIMULATED WITH STAPHYLOCOCCAL ENTEROTOXIN A, Pages 155-164, Marlyn P. Langford, Douglas A. Weigent, G. John Stanton, R.B. Pollard, Jay C. Fish, M. Wayne Flye
GAMMA (IMMUNE) INTERFERON PRODUCTION BY A PERMANENT HUMAN T-LYMPHOCYTE CELL LINE, Pages 165-171, Jerome E. Groopman, Ilana Nathan, David W. Golde
PURIFICATION OF LYMPHOTOXIN FROM RPMI-1788 CELL LINE SUPERNATE, Pages 173-183, S. Pichyangkul, N.O. Hill, A. Khan
THE IDENTIFICATION OF TWO NEW CLASSES OF LYMPHOTOXIN RELEASED BY LECTIN ACTIVATED HUMAN T LYMPHOCYTES THAT POSSESS IG-LIKE RECEPTORS, Pages 185-198, Robert S. Yamamoto, Paul C. Harris, Caron Christensen, Sally L. Orr, Jim Klostergaard, Gale A. Granger
PURIFICATION OF THE ALPHA-HEAVY CLASS OF HUMAN LYMPHOTOXIN TO ELECTROPHORETIC HOMOGENEITY, Pages 199-209, Jim Klostergaard, Sally L. Orr, Gale A. Granger
PRODUCTION OF LEUCOCYTE MIGRATION INHIBITORY FACTOR (LIF) BY HUMAN NATURAL KILLER (NK) CELLS, Pages 211-218, Ralph Ashorn, Kai Krohn, Eero Saksela, Tuomo Timonen
SPONTANEOUS PRODUCTION OF LEUCOCYTE MIGRATION INHIBITORY FACTOR (LIF) BY ESTABLISHED HUMAN LYMPHOID CELL LINES, Pages 219-227, Ralph Ashorn, Kai Krohn, Kenneth Nilsson
LYMPHOKINE INDUCED RELEASE OF BASOPHILIC HISTAMINE: SEPARATION OF THE ACTIVITY INTO TWO FACTORS, Pages 229-239, David O. Thueson, Diane E. Plank, Michael A. Lett-Brown, J. Andrew Grant
THE PHYSIOLOGICAL INTERFERON RESPONSE: THE SITES AND THE MEANING, Pages 241-255, Velio Bocci
INTERFERONS INDUCED IN HUMAN LEUKOCYTES BY MITOGENS : PRODUCTION, PARTIAL PURIFICATION AND CHARACTERIZATION, Pages 257-271, Marc De Ley, Joseph Van Damme, Alfons Billiau, Piet De Somer, Hendrik Claeys, Carl Vermylen
HUMAN INTERLEUKIN 1: PURIFICATION AND PROPERTIES, Pages 273-289, Lawrence B. Lachman
HUMAN (T,G)-A—L SPECIFIC HELPER FACTORS POSSESS VH AS WELL AS HLA-DR DETERMINANTS, Pages 291-302, Edna Mozes, Dvora Katz, Ron N. Apte, Zvi Bentwich, Tania Livshitz, Chaim Brautbar
PRODUCTION AND CHARACTERIZATION OF HUMAN GAMMA INTERFERON, Pages 303-321, S.H.S. Lee, C.L.Y. Lee, K.R. Rozee
HUMAN LYMPHOCYTE PRODUCTION OF NEUROENDOCRINE HORMONE-RELATED SUBSTANCES, Pages 323-332, J. Edwin Blalock, Eric M. Smith
NEUTROPHIL MIGRATION INHIBITION FACTOR FROM T-LYMPHOCYTES (NIF-T): SPECIFIC BINDING TO HUMAN PERIPHERAL BLOOD NEUTROPHILS AND NEUTROPHIL PRECURSORS, Pages 333-341, Richard H. Weisbart, Grace Chan, Aldons J. Lusis, David W. Golde, Ronald Billing, Robert F. Ashman
PRODUCTION AND BIOLOGICAL CHARACTERISATION OF LYMPHOID CELL-LINE LYMPHOKINE (LCL-LK) PREPARATIONS, Pages 343-352, H.A.M. Verheul, F.C. den Hollander, D.M. Dijkhuizen, J.W.L. Gijzen, J.G.M. Kessels, A.H.W.M. Schuurs
MACROPHAGE AGGLUTINATION ACTIVITY OF HUMAN PLASMA PROTEINS, Pages 353-360, H.P. Godfrey, A. Purohit
PURIFICATION OF HUMAN LYMPHOKINES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, Pages 361-377, J.E. McEntire, P. Dunn, B.W. Papermaster, C.W. Gehrke
HUMAN SERUM FACTOR INDUCING GIANT FAT CELL FORMATION IN HUMAN BONE MARROW CULTURE: NORMAL AND LEUKEMIC, Pages 379-395, Inna A. Svet-Moldavskaya, George J. Svet-Moldavsky, Svetlana N. Zinzar, Carol Vergara, James F. Holland, Zalmen Arlin, Benjamin Koziner, Bayard D. Clarkson
HUMAN LEUKOCYTE INTERFERON COMPRISES A CONTINUUM OF 13 INTERFERON SPECIES, Pages 397-416, Kurt Berg, Iver Heron
PURIFICATION FROM THE SERUM OF PATIENTS WITH RHEUMATOID ARTHRITIS OF A POLYCLONAL B CELL ACTIVATOR WITH ESTERASE ACTIVITY AND OF ITS LOW MOLECULAR WEIGHT INHIBITOR, Pages 417-434, Marius Teodorescu, Jenque-Yue Chang, Doina Ganea, John L. Skosey
RESISTANCE TO NATURAL-KILLER CELLS\' CYTOTOXICITY AND HLA SYNTHESIS: DIFFERING REGULATORY EFFICIENCY OF THE TYPE-I AND IMMUNE INTERFERONS, Pages 435-449, David Wallach
USE OF CYTOFLUOROMETRIC TECHNIQUES FOR ASSAY OF CELL CYCLE REGULATING LYMPHOKINES, Pages 451-458, Flemming Kristensen, Alain L. de Weck
LYMPHOKINE ADJUVANT THERAPY: BIOASSAY OF HUMAN LYMPHOKINE FRACTIONS IN A MOUSE TUMOR MODEL, Pages 459-477, Ben W. Papermaster, John E. McEntire, C. Dean Gill-Hand
THE SPECIES SPECIFICITY OF INTERLEUKIN-2, Pages 479-485, Peter Lindsay, Udo Schwulera, Hans H. Sonneborn
EFFECT OF HUMAN α-LYMPHOTOXIN ON TARGET-CELL PLASMA MEMBRANES, Pages 487-493, Werner Rosenau
LYMPHOTOXINS: AN NK-LIKE LT SYSTEM, Pages 495-507, Gale A. Granger, Monica L. Weitzen, James J. Devlin, Elizabeth Innins, Robert S. Yamamoto
SELECTIVE LYSIS OF NATURAL KILLER (NK) SENSITIVE TARGETS BY SOLUBLE CYTOTOXIC FACTORS (NKCF), Pages 509-517, Benjamin Bonavida, Nabil Hanna, Susan C. Wright
PHOSPHOLIPASE C ACTIVITY IN HUMAN INTERFERONS, Pages 519-525, Jerzy A. Georgiades, Jon I. Teng, Leland L. Smith
MECHANISMS OF INDUCTION OF HUMAN GAMMA INTERFERON, Pages 527-538, Ferdinando Dianzani, Thomas M. Monahan, Marina Santiano, Craig Jordan, Mario Zucca
ENHANCEMENT OF NATURAL KILLING ACTIVITY BY DIFFERENT TYPES OF INTERFERON, Pages 539-559, Douglas A. Weigent, Marlyn P. Langford, W. Robert Fleischmann Jr., G. John Stanton
GENETIC REGULATION OF THE IMMUNE RESPONSE TO (T,G)-A—L IN THE HUMAN, Pages 561-570, Dvora Katz, Daniel Suez, Edna Mozes, Zvi Bentwich, Tania Livshitz, Chaim Brautbar
INDUCTION OF CONCANAVALIN-A (CON-A) STIMULATED SUPPRESSIVE FACTORS IN ACUTE LYMPHOCYTIC LEUKEMIA (ALL), Pages 571-586, Nalini Mukhopadhyay, Donald J. Fernbach
ANGIOGENIC LYMPHOKINE FROM TRANSFORMED LYMPHOCYTES. A KEY TO THE UNDERLYING MECHANISMS IN ANGIOLYMPHOPROLIFERATIVE SYNDROMES (ALPS), Pages 587-594, Sergio DeCarvalho
REGULATORY ASPECTS OF LIF PRODUCTION BY CON-A STIMULATED MNC CULTURES, Pages 595-604, George Sandru, Peter Veraguth
CYSTIC FIBROSIS: FURTHER CHARACTERIZATION OF A “NEW” CYTOKINE WHICH MODULATES NEUTROPHIL AND MONOCYTE CHEMOTAXIS, Pages 605-620, Gregory B. Wilson, Harold D. Jackson
PRE-CLINICAL AND PHASE 1 CLINICAL TRIALS WITH LYMPHOTOXIN, Pages 621-631, Amanullah Khan, N.O. Hill, Helen Ridgway, Kristan Webb
PHASE I STUDY OF SYSTEMIC LYMPHOKINE (LCL-LK) ADMINISTRATION IN ADVANCED CANCER PATIENTS, Pages 633-639, Joaquim Gouveia, Patricia Ribaud, Antoine Goutner, Georges Mathé
SYSTEMATIC LYMPHOKINE TREATMENT OF SELECTED CANCER PATIENTS, Pages 641-650, BARBARA M. SOUTHCOTT, D.C. DUMONDE, M.S. PULLEY, E. VAN VLIET, F. DEN HOLLANDER, A. SCHUURS
HORMONAL, HAEMATOLOGICAL AND ACUTE PHASE PROTEIN RESPONSES OF ADVANCED CANCER PATIENTS TO THE INTRAVENOUS INJECTION OF LYMPHOID-CELL LYMPHOKINE (LCL-LK), Pages 651-664, Melanie S. Pulley, D.C. Dumonde, G. Carter, B. Muller, A. Fleck, Barbara M. Southcott, F. den Hollander
A HISTOLOGICAL STUDY OF INTRADERMAL AND INTRALESIONAL INJECTION OF HUMAN LYMPHOID CELL LINE LYMPHOKINE (LCL-LK) IN PATIENTS WITH ADVANCED CANCER, Pages 665-688, D.C. Dumonde, Melanie S Pulley, F. Paradinas, Barbara M. Southcott, D. O\'Connell, M.R.G. Robinson, F. den Hollander
THE MONITORING OF THE IMMUNOSUPPRESSIVE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY MEANS OF THE MIF PRODUCTION TEST, Pages 689-697, Jozef Rovenský, Dusan Zitnan, Ladislav Cebecauer, Jan Pekarek, Jan Svejcar
PHASE I CLINICAL STUDIES WITH LYMPHOBLASTOID LYMPHOKINE PREPARATIONS FROM THE RPMI 1788 CELL LINE, Pages 699-730, Ned D. Rodes, John E. McEntire, Pamela A. Dunn, Connie Gay, Miriam Decker, Carl G. Kardinal, C. Dean Gilliland, Ronald W. Oxenhandler, Ben W. Papermaster
INDEX, Pages 731-733